Published in Transplantation on September 01, 2015
Five-year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R. Hepatology (2016) 0.76
Clinically relevant interpretation of solid phase assays for HLA antibody. Curr Opin Organ Transplant (2016) 0.76
Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation. World J Gastroenterol (2015) 0.76
mTOR Inhibition Suppresses Posttransplant Alloantibody Production Through Direct Inhibition of Alloprimed B Cells and Sparing of CD8+ Antibody-Suppressing T cells. Transplantation (2016) 0.76
Prognostic factors for the evolution and reversibility of chronic rejection in pediatric liver transplantation. Clinics (Sao Paulo) (2016) 0.75
The Role of Humoral Alloreactivity in Liver Transplantation: Lessons Learned and New Perspectives. J Immunol Res (2017) 0.75
Impact of the Trough Level of Calcineurin Inhibitor on the Prevalence of Donor-Specific Human Leukocyte Antigen Antibodies During Long-Term Follow-Up After Pediatric Liver Transplantation: Antibody Strength and Complement-Binding Ability. Transplant Direct (2017) 0.75
Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med (2007) 9.44
Costimulation blockade with belatacept in renal transplantation. N Engl J Med (2005) 4.86
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet (2013) 4.62
Treatment of atypical hemolytic uremic syndrome and thrombotic microangiopathies: a focus on eculizumab. Am J Kidney Dis (2012) 2.48
Transplantation procedures in children with primary hyperoxaluria type 1: outcome and longitudinal growth. Transplantation (2009) 1.63
Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial. Liver Transpl (2002) 1.58
Mental and physical quality of life in actual living liver donors versus potential living liver donors: a prospective, controlled, multicenter study. Liver Transpl (2009) 1.47
In vitro and in vivo proof of tolerance after two-step haploidentical bone marrow and kidney transplantation of the same donor. Transplantation (2012) 1.39
Five-year safety and efficacy of belatacept in renal transplantation. J Am Soc Nephrol (2010) 1.31
Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors. Transplantation (2002) 1.27
The diagnosis and treatment of cholangiocarcinoma. Dtsch Arztebl Int (2014) 1.25
Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma. Int J Cancer (2013) 1.23
FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation. Transplantation (2005) 1.21
Twenty-one additional cases of familial renal glucosuria: absence of genetic heterogeneity, high prevalence of private mutations and further evidence of volume depletion. Nephrol Dial Transplant (2008) 1.16
Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells. Mol Cancer (2012) 1.14
A pharmacokinetic and clinical review of the potential clinical impact of using different formulations of cyclosporin A. Berlin, Germany, November 19, 2001. Clin Ther (2003) 1.10
Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma. Int J Cancer (2013) 1.09
[In Process Citation]. Rev Med Suisse (2015) 1.06
Serum levels of immunoglobulins and IgG subclasses in steroid sensitive nephrotic syndrome. Pediatr Nephrol (2002) 1.04
Association of four DNA polymorphisms with acute rejection after kidney transplantation. Transpl Int (2008) 0.98
Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease. Kidney Int (2010) 0.98
Liver transplantation in children with Alagille syndrome: indications and outcome. Pediatr Transplant (2006) 0.95
Living donor nephrectomy: flank incision versus anterior vertical mini-incision. Transplantation (2004) 0.95
Interleukin-2 receptor antagonist induction in modern immunosuppression regimens for renal transplant recipients. Transpl Int (2006) 0.95
FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation. Transplantation (2004) 0.95
Long-term outcome of liver transplantation for autoimmune hepatitis. Clin Transplant (2004) 0.94
Attention and executive functioning deficits in liver-transplanted children. Transplantation (2010) 0.94
Liver transplantation in children with progressive familial intrahepatic cholestasis. Transplantation (2007) 0.93
Is rituximab effective in childhood nephrotic syndrome? Yes and no. Pediatr Nephrol (2013) 0.92
One hundred thirty-two consecutive pediatric liver transplants without hospital mortality: lessons learned and outlook for the future. Ann Surg (2004) 0.91
Diaphragmatic hernia resulting in enterothorax following pediatric liver transplantation: a rare complication. Transplantation (2006) 0.91
Neurological involvement in children with E. coli O104:H4-induced hemolytic uremic syndrome. Pediatr Nephrol (2014) 0.90
3D CT modeling of hepatic vessel architecture and volume calculation in living donated liver transplantation. Eur Radiol (2003) 0.90
Hepatitis B virus immunization with an adjuvant containing vaccine after liver transplantation for hepatitis B-related disease: failure of humoral and cellular immune response. Transpl Int (2006) 0.90
Clinical relevance of autoantibodies after pediatric liver transplantation. Clin Transplant (2007) 0.90
Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation. Pediatr Transplant (2006) 0.89
Morbidity rate of reoperation in thyroid surgery: a different point of view. Swiss Med Wkly (2012) 0.87
Immediate postoperative intensive care treatment of pediatric combined liver-kidney transplantation: outcome and prognostic factors. Transplantation (2011) 0.87
T cell epitope mapping of JC polyoma virus-encoded proteome reveals reduced T cell responses in HLA-DRB1*04:01+ donors. J Virol (2013) 0.87
Hemorrhagic necrotizing pancreatitis with a huge pseudocyst in a child with Crohn's disease. Eur J Gastroenterol Hepatol (2010) 0.87
TCR bias and HLA cross-restriction are strategies of human brain-infiltrating JC virus-specific CD4+ T cells during viral infection. J Immunol (2012) 0.86
Neonates with severe infantile hepatic hemangioendothelioma: limitations of liver transplantation. Pediatr Transplant (2008) 0.86
Effect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanisms. Rev Med Virol (2012) 0.86
Sorafenib-induced severe acute hepatitis in a stable liver transplant recipient. Transplantation (2010) 0.85
Cost-effectiveness analysis of antiviral treatment in liver transplant recipients with HCV infection. Transpl Int (2013) 0.84
A new side effect of immunosuppression: high incidence of hearing impairment after liver transplantation. Liver Transpl (2006) 0.84
Everolimus-induced pneumonitis: report of the first case in a liver transplant recipient and review of treatment options. Transpl Int (2009) 0.84
Long-term outcomes after liver transplantation for deoxyguanosine kinase deficiency: a single-center experience and a review of the literature. Liver Transpl (2014) 0.83
Bladder tamponade due to vesical varices during orthotopic liver transplantation. Transpl Int (2008) 0.83
Short- and long-term results of liver transplantation in infants aged less than 6 months. Transplantation (2004) 0.83
A prospective study on living related kidney donors' quality of life in the first year: choosing appropriate reference data. Clin Transplant (2012) 0.83
Emergency liver transplantation in neonates with acute liver failure: long-term follow-up. Transplantation (2008) 0.83
The value of immunoprophylaxis for cytomegalovirus infection with intravenous immunoglobulin in pediatric liver transplant recipients receiving a low-dose immunosupressive regimen. Pediatr Transplant (2009) 0.83
Combined liver-kidney transplantation for children with autosomal recessive polycystic kidney disease (ARPKD): indication and outcome. Transpl Int (2013) 0.82
Simultaneous determination of HIV antibodies, hepatitis C antibodies, and hepatitis B antigens in dried blood spots--a feasibility study using a multi-analyte immunoassay. Clin Chem Lab Med (2005) 0.82
Everolimus and long-term outcomes in renal transplantation. Transplantation (2011) 0.82
The use of everolimus in pediatric liver transplant recipients: first experience in a single center. Pediatr Transplant (2011) 0.82
Pediatric transplantation: the Hamburg experience. Transplantation (2005) 0.81
Laparoscopic fenestration of posttransplant lymphoceles in children. J Pediatr Surg (2004) 0.81
Indications for and outcomes after combined lung and liver transplantation: a single-center experience on 13 consecutive cases. Transplantation (2008) 0.81
Mycophenolic acid exposure after administration of mycophenolate mofetil in the presence and absence of cyclosporin in renal transplant recipients. Clin Pharmacokinet (2009) 0.81
Resource use and treatment costs after kidney transplantation: impact of demographic factors, comorbidities, and complications. Transplantation (2004) 0.81
Response to cyclosporine in steroid-resistant nephrotic syndrome: discontinuation is possible. Pediatr Nephrol (2015) 0.80
Prevalence of polyomavirus viruria (JC virus/BK virus) in children following liver transplantation. Pediatr Transplant (2009) 0.80
Dual Inhibition of PI3K-AKT-mTOR- and RAF-MEK-ERK-signaling is synergistic in cholangiocarcinoma and reverses acquired resistance to MEK-inhibitors. Invest New Drugs (2014) 0.80
Liver allograft pathology in healthy pediatric liver transplant recipients. Pediatr Transplant (2013) 0.79
Everolimus and sirolimus in transplantation-related but different. Expert Opin Drug Saf (2015) 0.79
Elevated plasma and urine levels of ADMA and 15(S)-8-iso-PGF2alpha in end-stage liver disease. Hepatology (2003) 0.79
Potential clinical implications of substitution of generic cyclosporine formulations for cyclosporine microemulsion (Neoral) in transplant recipients. Eur J Clin Pharmacol (2004) 0.79
Analysis of the CC chemokine receptor 5Delta32 polymorphism in pediatric liver transplant recipients. Pediatr Transplant (2008) 0.79
Low N-acetyltransferase 2 activity in isoniazid-associated acute hepatitis requiring liver transplantation. Transpl Int (2009) 0.79
Successful outcome of severe Amanita phalloides poisoning in children. Pediatr Transplant (2013) 0.79
Fibroblast growth factor 23 and calcium phosphate homeostasis after pediatric renal transplantation. Pediatr Transplant (2012) 0.78
Neonatal hemochromatosis: long-term experience with favorable outcome. Pediatrics (2006) 0.78
Reperfusion of liver graft during transplantation: techniques used in transplant centres within Eurotransplant and meta-analysis of the literature. Transpl Int (2013) 0.78
The role of mammalian target of rapamycin inhibitors in the management of post-transplant malignancy. Clin Transplant (2014) 0.78
Donor quality of life up to two years after living donor liver transplantation: a prospective study. Transplantation (2014) 0.78
ADP-dependent platelet function prior to and in the early course of pediatric liver transplantation and persisting thrombocytopenia are positively correlated with ischemia/reperfusion injury. Transpl Int (2010) 0.78
Quality of life following living donor nephrectomy comparing classical flank incision and anterior vertical mini-incision. World J Urol (2005) 0.78
HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administration. J Hepatol (2007) 0.78
High B-cell activating factor is not associated with worse 3-year graft outcome in blood group-incompatible kidney transplantation with rituximab induction. Clin Transplant (2015) 0.78
Catheter visualization with resonant markers at MR imaging-guided deployment of endovascular stents in swine. Radiology (2004) 0.78